NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Akebia Therapeutics (NQ: AKBA)
11.03 USD  -0.56 (-4.87%)
Streaming Delayed Price  /  Updated: 1:31 PM EDT, Aug 4, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 589,103
Open 11.54
Bid (Size) 11.02 (8)
Ask (Size) 11.03 (1)
Prev. Close 11.59
Today's Range 10.76 - 11.64
52wk Range 2.990 - 13.71
Shares Outstanding 56,913,886
Dividend Yield N/A
Performance
YTD
+73.90%
+73.90%
1 Month
-15.58%
-15.58%
3 Month
+27.31%
+27.31%
6 Month
+40.00%
+40.00%
1 Year
+210.56%
+210.56%
Top News
More News
Akebia Therapeutics to Report Second Quarter 2020 Financial Results
Company announces database lock and plans to report top-line data from global Phase 3 PRO2TECT program of vadadustat for treatment of anemia due to chronic kidney disease in adult patients not on... Read More
from PR Newswire
Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19
The University of Texas Health Science Center at Houston to conduct study with up to 300 patients to evaluate use of Akebia's investigational drug, vadadustat, as potential therapy to lessen the... Read More
from PR Newswire
More News
Read More
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from PR Newswire
Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients
from PR Newswire
Akebia Therapeutics Launches AkebiaShares, a Peer-to-Peer Educational Program Series for the Renal Community
from PR Newswire
Akebia Therapeutics Announces New Chief Financial Officer
from PR Newswire
Akebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th ERA-EDTA Virtual Congress
from PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from PR Newswire
Akebia Therapeutics to Present at Jefferies Virtual Global Healthcare Conference
from PR Newswire
Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders
from PR Newswire
Akebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.